膳食钠摄入与多发性硬化风险无关联
该前瞻性队列研究基于护士健康研究(NHS)和护士健康研究II(NHSII),分别纳入80,920名和94,511名护士,通过每4年一次的食物频率问卷评估膳食钠摄入,随访期间共479例新发多发性硬化(MS)。调整年龄、纬度、 ancestry、BMI、维生素D、吸烟和总能量后,未发现膳食钠摄入与MS风险相关。
要点
- 膳食钠摄入最高五分位与最低五分位相比,MS风险无显著差异(HRpooled 0.98,95%CI 0.74-1.30)。
- 累积平均钠摄入同样与MS风险无关(HRpooled 1.02,95%CI 0.76-1.37)。
- 更极端十分位比较结果一致(p for trend = 0.95),不支持高钠增加MS风险。
核心结论
- 膳食钠摄入较高不增加多发性硬化发病风险,基线及累积平均摄入均无关联。
研究设计与样本
- 前瞻性队列研究,纳入NHS 80,920名护士(1984-2002)和NHSII 94,511名护士(1991-2007),随访期间479例新发MS。
主要发现
- 基线总钠摄入最高五分位(中位数NHS 3.2 g/d,NHSII 3.5 g/d)与最低五分位(NHS 2.5 g/d,NHSII 2.8 g/d)相比,HRpooled 0.98(95%CI 0.74-1.30),趋势P=0.75。
- 随访期间累积平均钠摄入最高五分位(中位数NHS 3.3 g/d,NHSII 3.4 g/d)与最低五分位(NHS 2.7 g/d,NHSII 2.8 g/d)相比,HRpooled 1.02(95%CI 0.76-1.37),趋势P=0.76。
- 更极端十分位比较结果相似,趋势P=0.95。
关键数值与推荐
- 膳食钠摄入通过每4年一次的经验证食物频率问卷评估,并利用验证研究数据校准。
- 采用Cox比例风险模型估计风险比(HR)和95%置信区间(CI),调整年龄、15岁居住纬度、ancestry、18岁BMI、补充维生素D摄入、吸烟和总能量摄入。
- 两项队列结果采用固定效应模型合并。
临床怎么用
- 对于多发性硬化风险担忧的人群,限制膳食钠摄入可能并非降低MS风险的有效策略。
- 临床咨询中不应将高钠饮食作为MS的独立危险因素进行干预。
局限性
- 研究对象为护士健康研究中的女性护士,结果外推至一般人群需谨慎。
- 膳食钠摄入依赖食物频率问卷自我报告,可能存在测量误差。
- 观察性研究不能完全排除残余混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To prospectively investigate the association between dietary sodium intake and multiple sclerosis (MS) risk. METHODS: In this cohort study, we assessed dietary sodium intake by a validated food frequency questionnaire administered every 4 years to 80,920 nurses in the Nurses' Health Study (NHS) (1984-2002) and to 94,511 in the Nurses' Health Study II (NHSII) (1991-2007), and calibrated it using data from a validation study. There were 479 new MS cases during follow-up. We used Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the effect of energy-adjusted dietary sodium on MS risk, adjusting also for age, latitude of residence at age 15, ancestry, body mass index at age 18, supplemental vitamin D intake, cigarette smoking, and total energy intake in each cohort. The results in both cohorts were pooled using fixed effects models. RESULTS: Total dietary intake of sodium at baseline was not associated with MS risk (highest [medians: 3.2 g/d NHS; 3.5 g/d NHSII] vs lowest [medians: 2.5 g/d NHS; 2.8 g/d NHSII] quintile: HRpooled 0.98, 95% CI 0.74-1.30, p for trend = 0.75). Cumulative average sodium intake during follow-up was also not associated with MS risk (highest [medians: 3.3 g/d NHS; 3.4 g/d NHSII] vs lowest [medians: 2.7 g/d NHS; 2.8 g/d NHSII] quintile: HRpooled 1.02, 95% CI 0.76-1.37, p for trend = 0.76). Comparing more extreme sodium intake in deciles yielded similar results (p for trend = 0.95). CONCLUSIONS: Our findings suggest that higher dietary sodium intake does not increase the risk of developing MS.
引用
- Cortese M, Yuan C, Chitnis T, et al. No association between dietary sodium intake and the risk of multiple sclerosis. Neurology. 2017. PMID: 28842447. doi:10.1212/WNL.0000000000004417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。